Creating a My Account with Xcel Peptides also gives you full access to: Order history Real-time shipment tracking And streamlined supportall in one place
Molecular Characteristics Molecular Type: Synthetic growth hormone fragment research peptide Structure: Linear peptide chain Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name AOD9604 6mg cas 386264-39-7 purity 99% (HPLC verified) unit Size 6 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored appropriately Analytical Validation and Quality Control High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and weight verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement AOD9604 6mg is supplied strictly for laboratory research and scientific investigation
It doesn't suppress natural hormone production or cause dependency
The combination of GLP-1 and GIP activation is what separates tirzepatide from pure GLP-1 agonists like semaglutide, and clinical data suggests the dual mechanism produces superior weight loss outcomes
High-intensity cardio is less important during this combination
Protein enrichment analysis showed that DPI and MitoQ single treatments induced a similar profile of downregulated peptides, affecting mainly members of the complex I of the mitochondrial respiratory chain and cell cycle/division proteins ( Supplementary Figures S3 , S4
